Jupiter Life Line Hospitals Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Jupiter Life Line Hospitals Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ₹4 per ₹100 of sales comes from others' credit, against ₹1 from others' credit three years earlier. Less money tied up than 95% of Healthcare companies in India.
- Debt Due Cover Ratio: Debt due within a year is covered 35.1 times by its yearly operating cash. Higher than 89% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹115Over the last 3 years, every ₹100 of reported profit came with ₹115 of operating cash.
Higher than 53% of Healthcare companies in India.
Self-Funding Ratio
0.7×Over the last 3 years its own operating cash paid for 71% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 76% of Healthcare companies in India.
Cash Locked Ratio
−₹4Money owed to suppliers is larger than money owed by customers plus stock: ₹4 per ₹100 of sales comes from others' credit, against ₹1 from others' credit three years earlier.
Less money tied up than 95% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹20Sales grew 68% in 3 years; of every extra ₹100 of sales, ₹20 became extra profit.
Higher than 59% of Healthcare companies in India.
Asset Productivity Ratio
+68% / +142%In 3 years sales changed by +68% while total assets changed by +142%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
35.1×Debt due within a year is covered 35.1 times by its yearly operating cash.
Higher than 89% of Healthcare companies in India.
Cash Cushion Ratio
−1%Debt, after subtracting cash, equals 1% of its market value (net debt).
Higher than 54% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 70% of Healthcare companies in India.
Tangible Net Worth Ratio
99%Of every ₹100 of net worth, ₹99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 70% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Jupiter Life Line Hospitals Limited owes ₹0.35 for every ₹1 it owns. Net profit rose 0% in the year to Mar 2026, and grew 39% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
44.0Investors pay ₹44.0 for every ₹1 of Jupiter Life Line Hospitals Limited's yearly profit, higher than 62% of Healthcare companies in India.
P/B ratio
5.16The share price is 5.16 times Jupiter Life Line Hospitals Limited's book value per share, higher than 58% of Healthcare companies in India.
Market cap
₹7,968 CrThe total market value of all of Jupiter Life Line Hospitals Limited's shares at today's price (share price × number of shares), larger than 59% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹1,544 CrWhat Jupiter Life Line Hospitals Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹47.10Net worth divided by the number of shares. The share price of ₹243.05 is 5.2 times this, which is the P/B above.
Return on equity (ROE)
11.7%Jupiter Life Line Hospitals Limited earned 11.7% on its shareholders' money over the last year, lower than 57% of Healthcare companies in India.
Owes vs Owns
0.35×Jupiter Life Line Hospitals Limited owes ₹0.35 for every ₹1 it owns (low), lower than 57% of Healthcare companies in India.
Dividend yield
0.08%Jupiter Life Line Hospitals Limited pays 0.08% of its share price as dividends a year, lower than 93% of dividend-paying Healthcare companies in India.
Revenue growth
+15%Revenue rose 15% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Profit growth
+0%Net profit rose 0% in the year to Mar 2026, and grew 39% a year on average over 3 years.
Profit margin
12.9%Jupiter Life Line Hospitals Limited keeps ₹13 of every ₹100 of revenue as net profit.
Cash quality
1.4×Cash from Jupiter Life Line Hospitals Limited's business was 1.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
9.4×Jupiter Life Line Hospitals Limited's operating profit covered its interest costs 9.4 times in the year to Mar 2026.
Cash vs debt
Net debtJupiter Life Line Hospitals Limited had ₹44 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Jupiter Life Line Hospitals Limited's P/E ratio?
Investors pay ₹44.0 for every ₹1 of Jupiter Life Line Hospitals Limited's yearly profit, higher than 62% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Jupiter Life Line Hospitals Limited: ₹7,968 Cr ÷ ₹1,544 Cr (31 Mar 2026) = 5.2.
What is Jupiter Life Line Hospitals Limited's return on equity?
Jupiter Life Line Hospitals Limited earned 11.7% on its shareholders' money over the last year, lower than 57% of Healthcare companies in India.
How much does Jupiter Life Line Hospitals Limited owe compared with what it owns?
Jupiter Life Line Hospitals Limited owes ₹0.35 for every ₹1 it owns (low), lower than 57% of Healthcare companies in India.
Does Jupiter Life Line Hospitals Limited pay a dividend?
Yes. Jupiter Life Line Hospitals Limited pays 0.08% of its share price as dividends a year, lower than 93% of dividend-paying Healthcare companies in India.
Is Jupiter Life Line Hospitals Limited's revenue growing?
Revenue rose 15% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.